CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:CellFuse Enables Multi-modal Integration of Single-cell and Spatial Proteomics data.
CellFuse Enables Multi-modal Integration of Single-cell and Spatial Proteomics data.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
单细胞和空间蛋白质组技术能够捕获互补的生物学信息,然而没有任何单一平台能够测量同一细胞内的所有模态。大多数现有的整合方法针对转录组数据进行了优化,并依赖于大量共享的、强关联的特征,这一假设在低维蛋白质组模态中往往不成立。我们提出了 CellFuse,一种基于深度学习的、模态无关的整合框架,专为特征重叠有限的场景而设计。CellFuse 利用监督对比学习来学习共享嵌入空间,从而实现准确的细胞类型预测以及跨模态和实验条件的无缝整合。在包括健康 PBMCs、骨髓、CAR-T 治疗的淋巴瘤以及健康和肿瘤组织在内的一系列数据集中,CellFuse 在整合质量和运行时间效率方面均持续优于现有方法。即使在存在缺失标志物和稀有细胞类型的情况下,它也能保持高准确度,并在跨数据集比较中表现稳健,使其成为基础研究和转化研究中可扩展且高保真单细胞数据整合的强大工具。
Single-cell and spatial proteomic technologies capture complementary biological information, yet no single platform can measure all modalities within the same cell. Most existing integration methods are optimized for transcriptomic data and rely on a large set of shared, strongly linked features, an assumption that often fails for low-dimensional proteomic modalities.
We present CellFuse, a deep learning-based, modality-agnostic integration framework designed specifically for settings with limited feature overlap. CellFuse leverages supervised contrastive learning to learn a shared embedding space, enabling accurate cell type prediction and seamless integration across modalities and experimental conditions.
Across a range of datasets including healthy PBMCs, bone marrow, CAR-T-treated lymphoma, and healthy and tumor tissues-CellFuse consistently outperforms existing methods in both integration quality and runtime efficiency. It maintains high accuracy even in the presence of missing markers and rare cell types, and performs robustly in cross-dataset comparisons, making it a powerful tool for scalable and high-fidelity single-cell data integration in basic and translational research.
MEMBER ACCOUNT
登录成功会直接打开下一页。